Digital Monitoring for Coronary Artery Disease

N/A

Recruiting

Research Sponsored by University of California, Davis

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

* Includes patients with coronary heart disease diagnosis and treatment with PCI who follow up at University of California Davis Health

Timeline

Screening 3 weeks

Treatment Varies

Follow Up six months

Summary

This trial tests a telemonitoring program for patients with coronary heart disease to improve patient outcomes and satisfaction after PCI. It will measure blood pressure, LDL, revascularization, mortality, and patient satisfaction.

Who is the study for?

This trial is for patients with coronary heart disease who have undergone a procedure called percutaneous coronary intervention (PCI) and are followed up at UC Davis Health. It's not suitable for individuals who don't meet these specific conditions.

What is being tested?

The study compares standard care with a telemonitoring program that includes remote monitoring, text-based follow-ups, health goals, education on using the app, and devices. The goal is to see if this reduces adverse cardiovascular events after PCI.

What are the potential side effects?

Since this trial involves digital monitoring rather than medication or invasive procedures, side effects may include privacy concerns or stress from constant health tracking but no physical side effects like those from drugs or surgeries.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ six months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~six months

This trial's timeline: 3 weeks for screening, Varies for treatment, and six months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

average ratings on the telehealth usability questionnaire

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Discharged with LiveCare and Text Message InterventionActive Control2 Interventions

Patients receive blood pressure monitoring and text messages reminders for enrollment in cardiac rehab, follow up appointment, diet and exercise counseling.

Group II: Discharged with Conventional CarePlacebo Group1 Intervention

Patients do not receive blood pressure monitoring and text messages reminders for enrollment in cardiac rehab, follow up appointment, diet and exercise counseling.

0 / 1Eligibility criteria met